BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublications en collaboration avec des chercheurs de University of Michigan–Ann Arbor (1)
2020
-
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Blood, Vol. 136, Núm. 21, pp. 2401-2409